Related references
Note: Only part of the references are listed.Oxidized low-density lipoproteins activate CD4(+) T cell apoptosis in patients with end-stage renal disease through Fas engagement
Pascal Meier et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients
Krystyna Pawlak et al.
ATHEROSCLEROSIS (2007)
Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease
J. W. Yoon et al.
KIDNEY INTERNATIONAL (2007)
Increased expression of heparanase in overt diabetic nephropathy
M. J. van den Hoven et al.
KIDNEY INTERNATIONAL (2006)
Induction of glomerular heparanase expression in rats with Adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system
Andrea Kramer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Matrix metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury
Sunfa Cheng et al.
FASEB JOURNAL (2006)
Priming of polymorphonuclear leukocytes: a culprit in the initiation of endothelial cell injury
J Jacobi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
The impact of heparanase and heparin on cancer metastasis and angiogenesis
Israel Vlodavsky et al.
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS (2006)
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Neta Ilan et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2006)
Cellular uptake of mammalian heparanase precursor involves low density lipoprotein receptor-related proteins, mannose 6-phosphate receptors, and heparan sulfate Proteoglycans
V Vreys et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Intravenous iron-gluconate during haemodialysis modifies plasma β2-microglobulin properties and levels
R Michelis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Primed peripheral polymorphonuclear leukocyte: A culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease
S Sela et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Down-regulation of hepatic LDL receptor-related protein (LRP) in chronic renal failure
C Kim et al.
KIDNEY INTERNATIONAL (2005)
Heparan sulfate proteoglycans in glomerular inflammation
ALWMM Rops et al.
KIDNEY INTERNATIONAL (2004)
Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis
E Edovitsky et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans
S Gingis-Velitski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inflammatory cytokines and fatty acids regulate endothelial cell heparanase expression
GP Chen et al.
BIOCHEMISTRY (2004)
Processing and activation of latent heparanase occurs in lysosomes
A Zetser et al.
JOURNAL OF CELL SCIENCE (2004)
Effects of high-flux hemodialysis on oxidant stress
RA Ward et al.
KIDNEY INTERNATIONAL (2003)
Neutrophil priming in host defense: Role of oxidants as priming agents
SD Swain et al.
ANTIOXIDANTS & REDOX SIGNALING (2002)
Heparanase: a key enzyme involved in cell invasion
CR Parish et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2001)
Involvement of peripheral polymorphonuclear leukocytes in oxidative stress and inflammation in type 2 diabetic patients
R Shurtz-Swirski et al.
DIABETES CARE (2001)
Proceedings of the High Blood Pressure Research Council of Australia - Carotid artery intima-medial thickness is increased in chronic renal failure
S Zoungas et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2000)
Share Paper
